Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy

Journal of the Neurological Sciences

Volumn 279, Issue 1-2, 2009, Pages 76-79

  Petzold, Axel ^a   Thompson, Edward J ^a   Keir, Geoffrey ^a   Quinn, Niall ^a   Holmberg, Bjorn ^b   Dizdar, Nil ^c   Wenning, Gregor K ^d   Rascol, Olivier ^e   Tolosa, Eduardo ^f   Rosengren, Lars ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^e CHU PURPAN   (France)

^f Institut Clínic de Neurociències ICN   (Spain)

Author keywords

Biomarker; Neurofilament; Nf heavy chain (NfH); Nf light chain (NfL)

Indexed keywords

HUMAN GROWTH HORMONE; NEUROFILAMENT PROTEIN; PLACEBO; PROTEIN SUBUNIT;

ADULT; AGED; ARTICLE; BRAIN PROTECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAVY CHAIN; HUMAN; IN VIVO STUDY; LIGHT CHAIN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHY DRAGER SYNDROME; STOICHIOMETRY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN GROWTH HORMONE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEUROFILAMENT PROTEINS; NEUROPROTECTIVE AGENTS; RECOMBINANT PROTEINS;

EID: 61449107994     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.12.037     Document Type: Article

References (14)

1. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 233 (2005) 183-198
2. Teunissen C.E., Dijkstra C., and Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol 4 (2005) 32-41
3. Holmberg B., Rosengren L., Karlsson J.E., and Johnels B. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. Mov Disord 13 (1998) 70-77
4. Holmberg B., Johansson J.O., Poewe W., Wenning G., Quinn N.P., Mathias C., et al. Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study. Mov Disord 22 (2007) 1138-1144
5. Rosengren L.E., Karlsson J.E., Karlsson J.O., Persson L.I., and Wikkelso C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 67 (1996) 2013-2018
6. Petzold A., Keir G., Green A.J.E., Giovannoni G., and Thompson E.J. A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods 278 (2003) 179-190
7. Scott D., Smith K.E., O B.J., Brien, and Angelides K.J. Characterization of mammalian neurofilament triplet proteins. Subunit stoichiometry and morphology of native and reconstituted filaments. J Biol Chem 260 (1985) 10736-10747
8. Petzold A., and Shaw G. Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain. J Immunol Methods 319 (2007) 34-40
9. Karlsson J.E., Rosengren L.E., and Haglid K.G. A rapid HPLC method to separate the triplet proteins of neurofilament. J Neurochem 49 (1987) 1375-1378
10. Julien J.P. Neurofilament functions in health and disease. Curr Opin Neurobiol 9 (1999) 554-560
11. Beaulieu J.M., Jacomy H., and Julien J.P. Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit. J Neurosci 20 (2000) 5321-5328
12. Meier J., Couillard-Despres S., Jacomy H., Gravel C., and Julien J.P. Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice. J Neuropathol Exp Neurol 58 10 (1999) 1099-1110
13. Perrone Capano C., Pernas-Alonso R., and di Porzio U. Neurofilament homeostasis and motoneurone degeneration. Bioessays 23 1 (2001) 24-33
14. Wong N.K.Y., He B.P., and Strong M.J. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J Neuropathol Exp Neurol 59 (2000) 972-982